Opinion|Articles|June 22, 2026
ASCO 2026 Lung Cancer Abstracts: Clinical Practice Implications
Author(s)Missak Haigentz, MD
Fact checked by: Sabrina Serani
Dr Haigentz breaks down 3 practice-changing ASCO 2026 lung cancer abstracts, from adjuvant targeted therapy to ADCs reshaping the immunotherapy backbone.
Advertisement
Advertisement
Every ASCO Annual Meeting brings a wave of new data, but only a handful of abstracts truly shift how practice. Missak Haigentz, MD, chief of Thoracic Medical Oncology and chief of Head & Neck Medical Oncology, Rutgers Cancer Institute/Jack & Sheryl Morris Cancer Center, discusses the 3 abstracts he considers to be standouts from this year’s meeting.
Advertisement
Advertisement